Chip Ganassi Racing is making a meaningful statement at the upcoming Indianapolis Grand Prix. Alongside the usual features of speed, sponsors, and a fresh paint job on Marcus Armstrong’s No. 11 Honda-powered car, the team is partnering with the Indiana University Melvin and Bren Simon Cancer Center and Schwartz Partners to raise awareness for cancer patients.
The crimson-and-cream paint scheme that will adorn Armstrong’s car is not just for aesthetics; it is scientifically-based and serves as a tribute to those battling cancer. This collaboration aims to shed light on the incredible work being done at the cancer center and emphasizes the importance of such facilities within the community.
John Schwartz, the general manager of Schwartz Partners, expressed the family’s desire to bring attention to the center that Dr. Kelvin Lee is affiliated with. He emphasized the privilege of having a facility like this in their community and the need for people to truly understand its significance.
This cause holds personal significance for both Chip Ganassi Racing and Marcus Armstrong. The team recently experienced the loss of Jeff Schwartz, brother of John Schwartz, who had been the CEO of Schwartz Partners. Jeff and his wife, Jill, were also board members for the Simon Cancer Center since 2019. The impact of cancer hits close to home for them, making this partnership deeply meaningful.
Another team member who has faced the challenges of cancer is Barry Wanser, the team manager for defending IndyCar Series champion Alex Palou. Wanser battled throat cancer last year, undergoing surgery and chemotherapy. Although he missed some races during that time, he has returned to the team this season. Wanser’s experience further highlights the importance of raising awareness and supporting cancer research.
Marcus Armstrong recognizes the significance of using motorsports as a platform for raising awareness. While watching a race can serve as a distraction from life’s difficulties, it can also be an opportunity to bring attention to important causes. Armstrong shared that the news of Wanser’s diagnosis came during last year’s race in August. This adds another layer of emotional connection to the Indianapolis Grand Prix for Armstrong and the team.
Armstrong has shown promise as a driver, with five top-10 finishes in the 2023 season and continued success this year. With the addition of oval races to his schedule, he has achieved two more top-10 finishes in four starts. Armstrong’s performance on the track is a testament to his dedication and skill, and now he can carry the message of hope with him as he competes in the Indianapolis Grand Prix.
As for the event itself, practice and qualifying are scheduled for Friday, leading up to the race on Saturday. The Indianapolis Motor Speedway’s 14-turn, 2.439-mile road course will be the stage for this thrilling event. And while the focus is on the Grand Prix, it’s worth noting that the iconic Indianapolis 500 is also on the horizon, set to take place on May 26 on the traditional 2.5-mile oval.
Chip Ganassi Racing’s partnership with the Indiana University Melvin and Bren Simon Cancer Center and Schwartz Partners not only adds a meaningful dimension to the Indianapolis Grand Prix but also highlights the importance of supporting cancer patients and research. By using motorsports as a platform for awareness, this collaboration brings attention to the incredible work being done within the community and serves as a reminder of the strength and resilience of those facing cancer.
